Table 2.
Advantages | Disadvantages | |
---|---|---|
Genotypic assays | ||
Direct PCR sequencing | Thorough identification of all mutations | Poor sensitivity (∼ 20%) |
Restriction fragment-length polymorphism | Sensitive to ∼ 5% | Requires separate endonuclease reactions for each mutation |
Reverse hybridization line probe assay | Sensitive | Requires specific probe for every mutation |
Commercially available | ||
DNA microchip | Able to detect new mutations | Expensive |
Not widely available | ||
Mass spectrometric analysis | Very sensitive | Requires new primer for each mutation |
Ultra-deep pyrosequencing | Sensitive to 0.1% | Early in development |
Phenotypic assays | ||
Transient transfection with site-specific mutagenesis | Rapid | Not applicable for multiple or complex mutations |
Good for single mutations | ||
Whole HBV genome amplification/cloning and transfection | Whole HBV genome variability | Requires cloning step |
Cross-resistance testing | ||
Cell transduction using Baculovirus vector | High levels of replication | Multiple vectors required |
Cross-resistance testing | ||
Permanent cell lines with expression of HBV mutant genome | Reproducible | New cell line needed for new mutations |
Cross-resistance testing |
HBV—hepatitis B virus; PCR—polymerase chain reaction